Stay updated on VELIA Clinical Trial: Veliparib in Ovarian Cancer
Sign up to get notified when there's something new on the VELIA Clinical Trial: Veliparib in Ovarian Cancer page.

Latest updates to the VELIA Clinical Trial: Veliparib in Ovarian Cancer page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedThe page now displays a 403 Forbidden error page, replacing the expected study record content. This indicates restricted access or an issue with the site that prevents viewing the study details.SummaryDifference18%

- Check21 days agoNo Change Detected
- Check35 days agoChange DetectedAdded a note for 2014 ( U.S. NIH Grant/Contract ) and updated the site revision to v3.6.6, replacing the previous v3.6.5.SummaryDifference0.0%

- Check49 days agoChange DetectedThe page now includes additional data-sharing information and links to the Statistical Analysis Plan and Study Protocol, expanding context for researchers, and an error page indicating an outage was removed, restoring access to the study record.SummaryDifference100%

- Check57 days agoChange DetectedThe page footer now lists Revision: v3.6.5, replacing the previous v3.6.4. This indicates a site revision update.SummaryDifference0.0%

- Check71 days agoChange DetectedFooter now shows Revision: v3.6.4, replacing v3.6.3, indicating a template update rather than a change to study content.SummaryDifference0.0%

- Check92 days agoChange DetectedThe page's revision tag was updated from v3.6.2 to v3.6.3, indicating a minor platform/documentation update.SummaryDifference0.0%

Stay in the know with updates to VELIA Clinical Trial: Veliparib in Ovarian Cancer
Enter your email address, and we'll notify you when there's something new on the VELIA Clinical Trial: Veliparib in Ovarian Cancer page.